Cargando…

Dulaglutide Protects Mice against Diabetic Sarcopenia-Mediated Muscle Injury by Inhibiting Inflammation and Regulating the Differentiation of Myoblasts

BACKGROUND: Type 2 diabetes mellitus increases the risk of sarcopenia, which is characterized by decreased muscle mass, strength, and function. However, there are no effective drugs to treat diabetic sarcopenia, and its underlying mechanism remains unknown. Here, we aimed to determine whether the GL...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Fengyi, Wu, Wenyan, Fan, Xingyu, Zhong, Xing, Wang, Nuojin, Wang, Yue, Pan, Tianrong, Du, Yijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10425251/
https://www.ncbi.nlm.nih.gov/pubmed/37584041
http://dx.doi.org/10.1155/2023/9926462
_version_ 1785089796315545600
author Deng, Fengyi
Wu, Wenyan
Fan, Xingyu
Zhong, Xing
Wang, Nuojin
Wang, Yue
Pan, Tianrong
Du, Yijun
author_facet Deng, Fengyi
Wu, Wenyan
Fan, Xingyu
Zhong, Xing
Wang, Nuojin
Wang, Yue
Pan, Tianrong
Du, Yijun
author_sort Deng, Fengyi
collection PubMed
description BACKGROUND: Type 2 diabetes mellitus increases the risk of sarcopenia, which is characterized by decreased muscle mass, strength, and function. However, there are no effective drugs to treat diabetic sarcopenia, and its underlying mechanism remains unknown. Here, we aimed to determine whether the GLP-1 receptor agonist (GLP-1RA) dulaglutide (Dul) affects the progression of diabetic sarcopenia. METHODS: db/db mice were injected intraperitoneally with 0.6 mg/kg dulaglutide for 10 weeks. Mouse muscle tissues were then pathologically evaluated and stained with F4/80 or MPO to detect macrophages and neutrophils, respectively. In addition, inflammatory factors and FNDC5 in the muscle tissues were detected using qRT-PCR. Moreover, C2C12 cells were induced to enable their differentiation into skeletal muscle cells, and muscle factor levels were then detected. Furthermore, changes in muscle factor levels were detected at various glucose concentrations (11 mM, 22 mM, and 44 mM). RESULTS: In vivo, dulaglutide alleviated muscle tissue injury; reduced levels of the inflammatory factors, IL-1β, IL-6, CCL2, and CXCL1; and reversed the level of FNDC5 in the muscle tissues of db/db mice. In vitro, a C2C12 cell differentiation model was established through the observation of cell morphology and determination of myokine levels. Upon stimulation with high glucose, the differentiation of C2C12 cells was inhibited. Dulaglutide improved this inhibitory state by upregulating the levels of both FNDC5 mRNA and protein. CONCLUSIONS: Treatment with the GLP-1RA dulaglutide protects db/db mice against skeletal muscle injury by inhibiting inflammation and regulating the differentiation of myoblasts. High glucose inhibited the differentiation of C2C12 cells and decreased the mRNA and protein levels of myokines. Dulaglutide could reverse the differentiation state induced in C2C12 cells by high glucose.
format Online
Article
Text
id pubmed-10425251
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-104252512023-08-15 Dulaglutide Protects Mice against Diabetic Sarcopenia-Mediated Muscle Injury by Inhibiting Inflammation and Regulating the Differentiation of Myoblasts Deng, Fengyi Wu, Wenyan Fan, Xingyu Zhong, Xing Wang, Nuojin Wang, Yue Pan, Tianrong Du, Yijun Int J Endocrinol Research Article BACKGROUND: Type 2 diabetes mellitus increases the risk of sarcopenia, which is characterized by decreased muscle mass, strength, and function. However, there are no effective drugs to treat diabetic sarcopenia, and its underlying mechanism remains unknown. Here, we aimed to determine whether the GLP-1 receptor agonist (GLP-1RA) dulaglutide (Dul) affects the progression of diabetic sarcopenia. METHODS: db/db mice were injected intraperitoneally with 0.6 mg/kg dulaglutide for 10 weeks. Mouse muscle tissues were then pathologically evaluated and stained with F4/80 or MPO to detect macrophages and neutrophils, respectively. In addition, inflammatory factors and FNDC5 in the muscle tissues were detected using qRT-PCR. Moreover, C2C12 cells were induced to enable their differentiation into skeletal muscle cells, and muscle factor levels were then detected. Furthermore, changes in muscle factor levels were detected at various glucose concentrations (11 mM, 22 mM, and 44 mM). RESULTS: In vivo, dulaglutide alleviated muscle tissue injury; reduced levels of the inflammatory factors, IL-1β, IL-6, CCL2, and CXCL1; and reversed the level of FNDC5 in the muscle tissues of db/db mice. In vitro, a C2C12 cell differentiation model was established through the observation of cell morphology and determination of myokine levels. Upon stimulation with high glucose, the differentiation of C2C12 cells was inhibited. Dulaglutide improved this inhibitory state by upregulating the levels of both FNDC5 mRNA and protein. CONCLUSIONS: Treatment with the GLP-1RA dulaglutide protects db/db mice against skeletal muscle injury by inhibiting inflammation and regulating the differentiation of myoblasts. High glucose inhibited the differentiation of C2C12 cells and decreased the mRNA and protein levels of myokines. Dulaglutide could reverse the differentiation state induced in C2C12 cells by high glucose. Hindawi 2023-08-07 /pmc/articles/PMC10425251/ /pubmed/37584041 http://dx.doi.org/10.1155/2023/9926462 Text en Copyright © 2023 Fengyi Deng et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Deng, Fengyi
Wu, Wenyan
Fan, Xingyu
Zhong, Xing
Wang, Nuojin
Wang, Yue
Pan, Tianrong
Du, Yijun
Dulaglutide Protects Mice against Diabetic Sarcopenia-Mediated Muscle Injury by Inhibiting Inflammation and Regulating the Differentiation of Myoblasts
title Dulaglutide Protects Mice against Diabetic Sarcopenia-Mediated Muscle Injury by Inhibiting Inflammation and Regulating the Differentiation of Myoblasts
title_full Dulaglutide Protects Mice against Diabetic Sarcopenia-Mediated Muscle Injury by Inhibiting Inflammation and Regulating the Differentiation of Myoblasts
title_fullStr Dulaglutide Protects Mice against Diabetic Sarcopenia-Mediated Muscle Injury by Inhibiting Inflammation and Regulating the Differentiation of Myoblasts
title_full_unstemmed Dulaglutide Protects Mice against Diabetic Sarcopenia-Mediated Muscle Injury by Inhibiting Inflammation and Regulating the Differentiation of Myoblasts
title_short Dulaglutide Protects Mice against Diabetic Sarcopenia-Mediated Muscle Injury by Inhibiting Inflammation and Regulating the Differentiation of Myoblasts
title_sort dulaglutide protects mice against diabetic sarcopenia-mediated muscle injury by inhibiting inflammation and regulating the differentiation of myoblasts
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10425251/
https://www.ncbi.nlm.nih.gov/pubmed/37584041
http://dx.doi.org/10.1155/2023/9926462
work_keys_str_mv AT dengfengyi dulaglutideprotectsmiceagainstdiabeticsarcopeniamediatedmuscleinjurybyinhibitinginflammationandregulatingthedifferentiationofmyoblasts
AT wuwenyan dulaglutideprotectsmiceagainstdiabeticsarcopeniamediatedmuscleinjurybyinhibitinginflammationandregulatingthedifferentiationofmyoblasts
AT fanxingyu dulaglutideprotectsmiceagainstdiabeticsarcopeniamediatedmuscleinjurybyinhibitinginflammationandregulatingthedifferentiationofmyoblasts
AT zhongxing dulaglutideprotectsmiceagainstdiabeticsarcopeniamediatedmuscleinjurybyinhibitinginflammationandregulatingthedifferentiationofmyoblasts
AT wangnuojin dulaglutideprotectsmiceagainstdiabeticsarcopeniamediatedmuscleinjurybyinhibitinginflammationandregulatingthedifferentiationofmyoblasts
AT wangyue dulaglutideprotectsmiceagainstdiabeticsarcopeniamediatedmuscleinjurybyinhibitinginflammationandregulatingthedifferentiationofmyoblasts
AT pantianrong dulaglutideprotectsmiceagainstdiabeticsarcopeniamediatedmuscleinjurybyinhibitinginflammationandregulatingthedifferentiationofmyoblasts
AT duyijun dulaglutideprotectsmiceagainstdiabeticsarcopeniamediatedmuscleinjurybyinhibitinginflammationandregulatingthedifferentiationofmyoblasts